Halunen Law’s False Claims Act Case Discussed in Forbes Magazine
November 24th, 2020
Rapid Covid-19 vaccine development shines light on pharma whistleblower cases. In a recent Forbes article Halunen Law’s False Claims Act suit against Tamiflu manufacturer Roche is highlighted and outlines the critical role Whistleblowers play in policing industry misconduct.
As the federal government continues to fund vaccine development and anticipates purchasing hundreds of millions, if not billions of dollars, on vaccine courses, the opportunity for fraud is ripe. Whistleblowers who are aware of fraudulent or noncompliant practices involving a Covid-19 vaccine, including issues with ongoing clinical trials, may be well positioned to bring a False Claims Act lawsuit to uncover the fraud and recover taxpayer dollars.